A detailed analysis of the structure of the medical enzymes industry has been conducted. Revenues are broken down by global region. Sales figures are estimated for the 5-year period from 2010 through 2015.
Applications or the uses of medical enzymes are also discussed separately in the report, with emphasis on the usage in various disease sectors. The report also covers the usage of enzymes for diagnostic purposes and in molecular research like sequencing, mapping, and so on. The report also covers significant patents and their number in each category.
REASONS FOR DOING THIS STUDY
A rapid increase in enzyme knowledge has resulted in harvesting the advantages of enzymes in almost every field of life. Enzymes are not only used for industrial purposes but also are used in various fields of the healthcare industry including therapeutics, diagnostics, and molecular research.
Modern industries have now begun to explore the advantages of enzymes in their production processes. This has led to a growing market for enzymes. Genetic engineering technology has made it possible to produce the enzymes in a form identical to the one that normally takes place in the human body.
The increasing competition, patent expirations, and new technologies are taking this industry in a new direction. Although the industry did see a setback in 2009 due to some manufacturing problems and FDA regulations, new advancements and increased spending in research and development are causing the market to grow. This study looks at almost all of the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs.
CONTRIBUTIONS of THE STUDY AND ITS INTENDED AUDIENCE
Copyright©2010 PR Newswire.
All rights reserved